229 related articles for article (PubMed ID: 33744849)
1. DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress.
Guo D; Ma D; Liu P; Lan J; Liu Z; Liu Q
Aging (Albany NY); 2021 Mar; 13(7):9874-9899. PubMed ID: 33744849
[TBL] [Abstract][Full Text] [Related]
2. DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.
Sun J; Wang X; Shen Q; Wang M; Chen S; Zhang X; Huang Y; Zhang Z; Li W; Yuan Y; Huang Z
Cell Oncol (Dordr); 2022 Dec; 45(6):1187-1202. PubMed ID: 36327092
[TBL] [Abstract][Full Text] [Related]
3. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.
Chang TM; Hung WC
Cancer Biol Ther; 2013 Mar; 14(3):222-9. PubMed ID: 23291986
[TBL] [Abstract][Full Text] [Related]
4. DNASE1L3 inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with β-catenin to promote its ubiquitin degradation pathway.
Li B; Ge YZ; Yan WW; Gong B; Cao K; Zhao R; Li C; Zhang YW; Jiang YH; Zuo S
Cell Prolif; 2022 Sep; 55(9):e13273. PubMed ID: 35748106
[TBL] [Abstract][Full Text] [Related]
5. DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection.
Wang S; Ma H; Li X; Mo X; Zhang H; Yang L; Deng Y; Yan Y; Yang G; Liu X; Sun H
Aging (Albany NY); 2020 Jan; 12(2):1171-1185. PubMed ID: 31977318
[TBL] [Abstract][Full Text] [Related]
6. Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis.
Takano M; Shimada K; Fujii T; Morita K; Takeda M; Nakajima Y; Nonomura A; Konishi N; Obayashi C
BMC Cancer; 2016 Nov; 16(1):903. PubMed ID: 27863477
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
8. DNase1L3 suppresses hepatocellular carcinoma growth via inhibiting complement autocrine effect.
Chen QY; Li L; Suo DQ
Neoplasma; 2021 Jul; 68(4):683-691. PubMed ID: 33618518
[TBL] [Abstract][Full Text] [Related]
9. The zinc finger protein GATA4 induces mesenchymal-to-epithelial transition and cellular senescence through the nuclear factor-κB pathway in hepatocellular carcinoma.
Xiang Q; Zhou D; He X; Fan J; Tang J; Qiu Z; Zhang Y; Qiu J; Xu Y; Lai G
J Gastroenterol Hepatol; 2019 Dec; 34(12):2196-2205. PubMed ID: 30995348
[TBL] [Abstract][Full Text] [Related]
10. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
11. Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism.
Xiao Y; Yang K; Liu P; Ma D; Lei P; Liu Q
Int J Biol Sci; 2022; 18(1):82-95. PubMed ID: 34975319
[TBL] [Abstract][Full Text] [Related]
12. Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1.
Lin N; Meng L; Lin J; Chen S; Zhang P; Chen Q; Lin Y
J Cell Biochem; 2020 Feb; 121(2):1441-1451. PubMed ID: 31609020
[TBL] [Abstract][Full Text] [Related]
13. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
[TBL] [Abstract][Full Text] [Related]
14. circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma.
Chen Z; Zuo X; Pu L; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cancer Sci; 2019 Feb; 110(2):568-581. PubMed ID: 30520539
[TBL] [Abstract][Full Text] [Related]
15. HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.
Wang L; Tong D; Guo Q; Wang X; Wu F; Li Q; Yang J; Zhao L; Qin Y; Liu Y; Huang C
Sci Rep; 2018 Feb; 8(1):2431. PubMed ID: 29402992
[TBL] [Abstract][Full Text] [Related]
16. Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma.
Guo P; Wang Y; Dai C; Tao C; Wu F; Xie X; Yu H; Zhu Q; Li J; Ye L; Yu F; Shan Y; Yu Z; Dhanasekaran R; Zheng R; Chen G
Oncogene; 2018 Mar; 37(9):1220-1236. PubMed ID: 29242604
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients.
Lv Z; Weng X; Du C; Zhang C; Xiao H; Cai X; Ye S; Cheng J; Ding C; Xie H; Zhou L; Wu J; Zheng S
Mol Carcinog; 2016 May; 55(5):1024-33. PubMed ID: 26086159
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
19. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma.
Yang Y; Zhang J; Xia T; Li G; Tian T; Wang M; Wang R; Zhao L; Yang Y; Lan K; Zhou W
Oncol Rep; 2016 Nov; 36(5):2553-2562. PubMed ID: 27666683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
